YSYulia V. Stepenko

Yulia V. Stepenko

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Yulia V. Stepenko has a total of 127 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Heterogeneity of senior medical students' knowledge on COPD pharmacotherapy: results of cluster analysis within the multicenter ASCO-IV study

    by D. B. Bontsevich, D. B. Turmukhametov, I. A. Zhdanov, O. F. Veselova, I. V. Gatskikh, G. M. Bikkinina, V. A. Nevzorova, I. M. Martynenko, Yu. V. Stepenko, G. I. Zavitkevich, et al.

    Introduction . Chronic obstructive pulmonary disease (COPD) remains one of the leading causes of morbidity and mortality, requiring future physicians to have solid knowledge of diagnosis and pharmacotherapy. Objective . To assess the level of basic knowledge of senior medical students on COPD and, using cluster analysis, to identify stable competency profiles across key domains (etiology, diagnosis, pharmacotherapy, and vaccination prophylaxis). Materials and methods . As part of the fourth stage of the multicenter ASCO-IV project, an anonymous survey was conducted among 480 senior medical students from five Russian medical universities (October 2023 — May 2025). A validated original 21-item closed-ended questionnaire was used, covering etiology, diagnosis, classification, pharmacotherapy, and vaccination prophylaxis of COPD. Descriptive statistics, nonparametric tests (Kruskal-Wallis, Dunn, χ²), hierarchical cluster analysis, k-means clustering, and discriminant analysis were applied; significance was set at p < 0.05 with Bonferroni correction. Results . The median individual mean score was 65.9 % [49.4 %; 77.8 %], with significant intercenter differences (H = 102; df = 4; p < 0.0001). Four stable clusters were identified: “Students with basic knowledge” (23.5 %), “Students with fragmented knowledge” (24.2 %), “Students with a high level of knowledge” (29.6 %), and “Students with a pronounced knowledge deficit” (22.7 %). Discriminant analysis confirmed high model accuracy — 94.8 % correct classification (λ = 0.033; p < 0.001). A “clinical-pharmacological gap” was revealed: diagnostic items (1-7) were mastered at an acceptable level (mean completeness 42–92 %), whereas pharmacotherapy, especially initial maintenance therapy (items 12, 14) and antimicrobial therapy of exacerbations (items 16-19), caused persistent difficulties for most students, including the high-knowledge cluster. The association between training center and cluster type was significant (χ² = 68.25; df = 12; p < 0.001). Discussion . The identified knowledge profiles justify a transition to differentiated educational strategies: deepening complex pharmacotherapy topics for the basic-knowledge cluster, systematizing material for the fragmented-knowledge cluster, returning to the basic course for the knowledge-deficit cluster, and engaging the high-knowledge cluster in research and Olympiad activities. Study limitations include the cross-sectional design and unbalanced sample across centers. The findings are consistent with the KNOCAP-III project and indicate a systemic nature of deficits in respiratory medicine teaching.

  • Open Access

    Analysis of medical students' knowledge about bronchial asthma: a multicenter study ASSA-IV

    by R. A. Bontsevich, G. I. Zavitkevich, O. F. Veselova, I. V. Gatskikh, V. A. Nevzorova, I. M. Martynenko, G. M. Bikkinina, Yu. V. Stepenko, Р. А. Бонцевич, Г. И. Завиткевич, et al.

       Introduction.  The high prevalence of asthma in the general population necessitates the assessment of medical students' theoretical knowledge regarding the pathogenesis, diagnosis, and management of this disease.    Aim.  To determine the level of basic knowledge among senior medical students across key thematic blocks of asthma.  Materials and methods.  The fourth stage of the multicenter study "The Assessment of Physicians' (Medical Students') Knowledge in the Field of Bronchial Asthma" (ASSA) was conducted between October 2023 and May 2025 using a validated, author-developed questionnaire based on current national and international clinical guidelines. The questionnaire consistedof 21 questions divided into two blocks: "Etiopathogenesis" and "Pharmacotherapy".    Results. A total of 487 correctly completed questionnaires from 5 universities of the Russian Federation were analyzed. The average rate of correct answers (ARC) for the entire questionnaire was 69.9 % (95 % CI 68.5–71.3 %), with a median (Me) of 70.6 % [IQR: 59.5%–82.5 %]. In the "Etiopathogenesis" section, the ARC reached 84.0% (95% CI 82.5–85.4 %), whereas in the "Pharmacotherapy" section it was only 59.3 % (95 % CI 57.6–61.0 %). The maximum ARC values were obtained for questions regarding asthma control levels (96.3 %) and the definition of the term "status asthmaticus" (92.6 %). Conversely, the minimum values were recorded for questions concerning sublingual immunotherapy for house dust mite allergies (16.2 %) and add-on therapy at the 4 th step of treatment (27.7%). Significant inter-center differences were revealed across the entire questionnaire (H (4) = 53.263, p < 0.001, ε2 = 0.102) and its individual sections. When compared with the previous stage (ASSA-III), a statistically significant improvement in the results was observed: the overall ARC increased by 3.9 % (69.9 % vs. 66.0 %, p < 0.001), though the effect size remained weak (r = 0.119; CLES = 0.568).    Conclusion.  Senior medical students demonstrated a proficient level of knowledge regarding the etiopathogenesis and diagnosis of asthma, whereas their understanding of its pharmacotherapy remains insufficient. The significant inter-center variability in the average rate of correct answers underscores the urgent need to standardize educational methods and strengthen practical training in asthma management and treatment selection.

  • Open Access

    Therapeutic potential of HSP70 in correcting cognitive deficits and its effect on beta-amyloid formation in Alzheimer’s Disease

    by E. V. Kuzubova, Yu. V. Stepenko, A. I. Radchenko, A. O. Rumyantseva, M. A. Rzhevskaya, A. A. Apostol, N. S. Zhunusov, A. Yu. Adonina, E. B. Artyushkova, O. S. Gudyrev, et al.

    Alzheimer’s disease (AD) is characterized by the progressive accumulation of beta-amyloid and impaired cognitive function. Existing treatments are not effective enough, it’s necessary to search for new therapeutic strategies targeting key pathogenetic mechanisms. The aim. To investigate the therapeutic potential of intracellular and extracellular forms of heat shock protein HSP70 for correcting cognitive deficits and reducing amyloid load in AD. Materials and methods. The study was performed on APPswe/PS1dE9/Blg transgenic mice, modeling AD, and lines created on their basis expressing intracellular (Tg_h) or extracellular (Tg_h_mod) forms of human HSP70. Behavioral tests were used to assess cognitive functions: Open Field, Novel Object Recognition, Y-maze, Barnes Maze. Amyloid load was assessed by histological method. Results. The extracellular form of HSP70 (Tg_h_mod) significantly reduced amyloid load by 37% ( p = 0.0033) and demonstrated marked cognitive improvement — by 40–45% in the Y-maze and Barnes Maze tests, whereas the intracellular form (Tg_h) reduced amyloidosis by 23.6% ( p = 0.0273) but did not show significant memory recovery. The results indicate that the neuroprotective effect of extracellular HSP70 is likely mediated not only by chaperone activity but also by additional mechanisms critical for synaptic function. Conclusion. A comparative study of the effectiveness of intracellular and extracellular forms of HSP70 in correcting both molecular and behavioral disorders in an AD model was conducted for the first time. It was found that the modified form of HSP70 has therapeutic potential. HSP70, especially its extracellular form, is a promising target for the development of AD therapy, providing a comprehensive effect on amyloid pathology and cognitive functions.

  • Open Access

    The potential of the peptide drug Semax and Its derivative for correcting pathological impairments in the animal model of Alzheimer’s disease

    by Alexandra Radchenko, Elena Kuzubova, Alina Apostol, Vladimir Mitkevich, Liudmila Andreeva, Svetlana Limborskaya, Yu. Stepenko, Veronika Shmigerova, Alexei Solin, Mikhail Korokin, et al.

    Alzheimer’s disease, first described over a century ago, is currently among the most common neurodegenerative diseases whose significance is increasingly growing with the aging of populations. Throughout the entire period of its study, no remedies have been found that would be effective in treating – or at least significantly slowing – the pathological process, while being sufficiently safe. In this regard, significant attention is paid to the development and application of natural peptide drugs lacking side effects. The present study assessed the effect of the known neuroprotective peptide Semax and its derivative on the behavioral characteristics and development of amyloidosis in transgenic APPswe/PS1dE9/Blg mice acting as a model of Alzheimer’s disease. The open field, novel object recognition, and Barnes maze tests demonstrated that both Semax and its derivative improved cognitive functions in mice. Histological examination showed that these peptides reduced the number of amyloid inclusions in the cortex and hippocampus of the animals’ brains. These findings demonstrate the high potential of Semax and its derivatives when used to develop therapeutic and corrective strategies for Alzheimer’s disease.


  • Knowledge of amoxicillin usage regimen by senior medical students

    by E. S. Ukhova, M. L. Maksimov, M. A. Plyasheshnikov, G. M. Bikkinina, E. N. Bochanova, I. V. Gatskikh, O. F. Veselova, G. G. Ketova, R. B. Eshanov, Yu. V. Stepenko

    Antibiotics play a crucial role in the treatment of bacterial infections, but their improper use leads to the development of antibiotic resistance among microorganisms. This study analyzes the level of knowledge about amoxicillin administration among senior medical students using anonymous questionnaires, descriptive statistics, and the StatTech software version 4.8.11. The research was conducted as part of the multicenter project KANT («Physicians’ (Students’) Knowledge in Antimicrobial Usage»), aimed at assessing the competence of physicians and future healthcare professionals regarding antibiotics. It has been found that most respondents are unaware of the recommended dosage for amoxicillin, with only less than one-quarter having accurate information on its frequency of prescription. Based on these findings, it is necessary to pay special attention to issues related to antimicrobial therapy within therapeutic disciplines and clinical pharmacology courses for medical students.

  • Knowledge of amoxicillin usage regimen by senior medical students

    by E. S. Ukhova, R. A. Bontsevich, M. L. Maksimov, M. A. Plyasheshnikov, G. M. Bikkinina, E. N. Bochanova, I. V. Gatskikh, O. F. Veselova, G. G. Ketova, R. B. Eshanov, et al.

    Antibiotics play a crucial role in the treatment of bacterial infections, but their improper use leads to the development of antibiotic resistance among microorganisms. This study analyzes the level of knowledge about amoxicillin administration among senior medical students using anonymous questionnaires, descriptive statistics, and the StatTech software version 4.8.11. The research was conducted as part of the multicenter project KANT («Physicians’ (Students’) Knowledge in Antimicrobial Usage»), aimed at assessing the competence of physicians and future healthcare professionals regarding antibiotics. It has been found that most respondents are unaware of the recommended dosage for amoxicillin, with only less than one-quarter having accurate information on its frequency of prescription. Based on these findings, it is necessary to pay special attention to issues related to antimicrobial therapy within therapeutic disciplines and clinical pharmacology courses for medical students.

  • Open Access

    Nonclassical cardiovascular effects of imidazoline receptor agonists

    by Yulia V. Stepenko, Olesya V. Shcheblykina, Anna A. Peresypkina, Veronika S. Shmigerova, Yomna Y.O.M. Akhmed, Tatiana A. Denisyuk, Anton P. Danilenko, Nikita S. Lyapkalov, Elena A. Shmykova, Lyudmila M. Danilenko

    Introduction: Imidazoline receptors are a group of metabotropic receptors whose activation is associated with changes in a number of functional parameters, including hemodynamics (lowering blood pressure (BP), negative chrono-and inotropic effects), metabolic metabolism (reducing insulin resistance, increasing high-density lipoproteins (HDL) levels) and hemorheology (antiplatelet activity). In addition, the spectrum of molecular pharmacological effects of imidazoline receptor (IR) agonists includes anti-inflammatory, antioxidant, and antifibrinolytic activities. Materials and Methods: Literature sources were searched using PubMed and Google Scholar databases, including such article types as meta-analysis, randomized controlled trial, and review. The inclusion criteria were full availability of data, scientific significance, and relevance of research. Results and Discussion: Experimental studies in animals revealed such effects of agonists IR as a decrease in the degree of left ventricular hypertrophy (LVH) and interleukin expression. The experience of using agonists IR therapy in clinical practice has revealed its effectiveness in the treatment of patients with chronic heart failure (CHF) II-IIIof NYHA class II-III NYHA with an ejection fraction of less than 40%, arterial hypertension (AH) and microalbuminuria. Conclusions: In general, the totality of data available to date indicates a high expediency of including imidazoline receptors in the repertoire of pharmacological targets, the impact on which can affect not only soft, but also hard endpoints in the treatment of cardiovascular pathology.

  • Open Access

    Predictive analysis and prediction of the main molecular targets for the N-acetyl-6-aminohexanoate derivative

    by Anton P. Danilenko, Alexey A. Khentov, Alexey V. Kuznetsov, Veronika S. Shmigerova, Yulia V. Stepenko, Alla P. Tarasova, Vladimir I. Yakushev, Elizaveta V. Boeva, Albina V. Miller, Irina A. Tatarenkova, et al.

    Introduction: N-acetyl-6-aminohexanoate (acexamic acid) and its derivatives are actively studied as promising compounds for the creation of new drugs, but their pharmacokinetic parameters and detailed mechanisms underlying a wide range of biochemical activities are still unclear. Materials and Methods: PASS Online, Molinspiration Property Calculation Service and OSIRIS Property Explorer were used for predictive analysis. To determine the molecular biomarkers of the N-acetyl-6-aminohexanoate derivative – 2-ethyl-6-methyl-3-hydroxypyridinium N-acetylhexanoic acid, ADMET (Absorption, Distribution, Metabolism, Excretion, Toxicity) parameters were predicted. Molecular docking was performed using GalaxyWEB Sagittarius service followed by evaluation of the results using RCSB Protein Data Bank and UniProt Consortium databases. Results: The study of the pharmacokinetic properties of 2-ethyl-6-methyl-3-hydroxypyridine N-acetyl-6-aminohexanoate revealed its potential suitability as a promising drug with high bioavailability. The highest degree of affinity is predicted with the eNOS center – binding energy from -7.2 to -8.3 kcal/mol; the VEGF center – binding energies from -6.1 to -7.7 kcal /mol, and the RANKL centre – binding energies from - 6.0 - 6,9 kcal mol. Conclusion: The results of predictor analysis and molecular docking suggest that the N-acetyl-6-aminohexanoate-2-ethyl-6-methyl-3-hydroxypyridinium derivative is a safe and promising compound. Potential biotargets include eNOS, VEGF, and RANKL.


  • Open Access

    Investigation of the pharmacological activity of the tetrapeptide HAEЕ, zinc, and human serum albumin in a transgenic mouse model with tau protein overexpression (P301S)

    by Veronika S. Shmigerova, Yulia V. Stepenko, Alexandra A. Kurbatova, Nikita S. Zhunusov, Nikita S. Lyapkalov, Maria S. Sviridova, Tatyana V. Avtina, Arkadiy V. Nesterov, Alexander A. Popov, Natalia I. Nesterova, et al.

    Introduction: Neurodegenerative diseases affecting neurons represent a wide spectrum of pathological conditions. To slow the accumulation of pathological tau protein, therapeutic interventions such as a pharmaceutical composition consisting of the tetrapeptide HAEЕ, zinc, and albumin may be employed. This composition possesses properties that can potentially slow disease progression. Materials and Methods: The experiment was performed on 60 homozygous mice of both sexes from a transgenic line with the overexpression of human mutant tau protein (P301S) and on 20 mice from a wild-type C57Bl/6J background line. Control groups (C57Bl/6J – K and P301S – K+) received NaCl injection water (100 µL subcutaneously, once every 2 days); the experimental group (P301S) received HAEE-Zn-HSA (75 mg/kg, 150 µL subcutaneously, once every 2 days); and the comparison group (P301S) received piracetam (1.75 g/kg, 175 µL subcutaneously, once every 2 days). Behavioral activity was analyzed using tests at two time points, and the phenotypic presentation and lifespan were evaluated. Results and Discussion: The P301S group of mice treated with HAEE-Zn-HSA at a dosage of 75 mg/kg showed positive behavioral activity in the following tests: Open Field, Novel Object Recognition, and Inverted grid test, indicating increased exploratory activity, and improved motor function and coordination in the mice of this group. Pharmacological intervention with HAEE-Zn-HSA in the experimental group of transgenic mice demonstrated positive results, as a statistically significant effect on lifespan and delayed onset of the phenotypic presentation of the disease was shown (24±2.14 weeks, p≤0.05). Conclusion: The pharmaceutical composition HAEE-Zn-HSA at a dosage of 75 mg/kg, using a model of homozygous mice from a transgenic line with overexpression of human mutant tau protein P301S, demonstrated high levels of adaptive and exploratory activity and improved motor function.


  • Open Access

    Investigator’s influence on the muscle strength assessment in animals in experiment: Comparison of automated “inverted grid” test and its classical variant

    by P. R. Lebedev, E. V. Kuzubova, В. М. Покровский, A. I. Radchenko, S. I. Osipyan, Yu. V. Stepenko, A. A. Apostol, L. M. Danilenko, A. A. Dolzhikov, T. G. Pokrovskaya, et al.

    The aim of the work was to study the influence of the researcher on the muscle strength assessment in animals in the experiment by comparing the results of the automated “inverted grid” test and its classical variant.Materials and methods. Male lines (Bla/J, n=20; FUS(1-359), n=20; Tau P301S+/+, n=20) and their background controls (C57BL/6J, n=20; CD1, n=20) were selected for the study. The dynamics of changes in the muscle deficit of the animals was evaluated in the automated and classical variant of the “inverted grid” test.Results. According to the results of the muscle strength assessment of mice with an edited genome of lines FUS(1-359)+/-, Tau P301S+/+, B6.ADysfprmd/GeneJ, using the “inverted grid” test in the classical variant and the automated one, it was found that statistically significant differences were not obtained in comparison with the results obtained by the classical variant of the test. The standard error of the mean increases by 23–39% in the classical test compared to the automated one. It was shown that the standard error of the mean in the classical variant of the test in Tau P301S+/+ mice was 6.24; 5.94; 5.88; 7.38 at 4 age points; in FUS(1-359)+/- mice, 4.49; 6.8; 6.98 and 4.1; B6.ADysfprmd/GeneJ mice, 7.66; 7.58; 8.3 and 7.92, respectively.Conclusion. Thus, the value of the standard error of the results study mean of the changes dynamics in the muscle strength when using the automated variant of the “inverted grid” test was reduced in comparison with the results of the classical variant of the test. The results of the study show that the automation of generally recognized behavioral tests is able to increase the accuracy of the obtained data reducing the influence of a human factor on the manipulation.